Home » Newsletters » BioWorld Science

BioWorld Science

July 4, 2001

View Archived Issues

Hollis-Eden receives approval to begin U.S. clinical trials with HE-2200

Enrollment completed in phase III clinical trial of T-20

Glycogen synthase 3 as a novel therapeutic target in type 2 diabetes

U.S. and French researchers investigate novel peptide vectors for gene, protein delivery

Potent analogues of hPTH and hPTHrP with bone anabolic effects

Gene and cell cycle effects elucidated for NB-1011

Orphan Medical receives approvable letter for Xyrem from FDA

Microbiological efficacy and safety of oritavancin in Gram-positive bacteremia

Nippon Shinyaku to market and distribute DepoCyt in Japan

Nexell submits IND for blood stem cell therapy as treatment of CGD

Aspirin-like compound exerts promising anti-HIV activity via a novel mechanism of action

Insulin sensitization with rosiglitazone may have numerous beneficial effects

Cyberonics launches VNS therapy for depression in Europe

Company begins phase I evaluation of XTL-002 for treatment of HCV

Schering-Plough seeks FDA approval for new formulation of PEG-Intron

Preliminary clinical results reported for Durect's Chronogesic

Old drug for diabetic neuropathy may be useful in migraine prophylaxis

PowderJect acquires SBL Vaccin

New LTB4 antagonists designed at Lilly for inflammation

Inhibitors of phosphodiesterase, TNF-alpha production and their use described by Merck

Cytovia presents new series of caspase activators and apoptosis inducers

Ortho-McNeil describes novel inflammatory cytokine inhibitors

Thrombopoietin mimetics in development at GSK

New NAALADase inhibitors from Guilford protect against cerebral ischemic insult

Neurogen's benzodiazepine-site ligands particularly useful for Rx of CNS disorders

Celgene team patents inhibitors of PDE4, TNF-alpha production and NF-kB activation

Xanthine-based adenosine receptor antagonists with particular utility in heart and renal failure

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...